Billionaire Profile

Global Rank

#2762

Image: Underwaterbuffalo | CC BY-SA 4.0 | via Wikimedia Commons

Jin Lei

CEO, Pharmaceuticals

CHINA

Real-Time Net Worth

$1.301B

Estimated based on Pharmaceuticals stock value as of March 6, 2026

+0.04% (24h)

Age

Source

Pharmaceuticals

Industry

Healthcare

Citizenship

CHINA

Biography

Jin Lei, a prominent figure in the pharmaceutical industry, is recognized for his significant contributions to the field. With an estimated net worth of $263 million as of January 2026, Jin Lei is the founder and chairman of Beijing Balance Medical Technology, a supplier of treatments for soft tissue repair. His career includes founding Jinsai Pharmaceutical in 1997, which launched China's first domestically produced recombinant human growth hormone powder injection, breaking foreign monopolies. His achievements and strategic decisions have positioned him as a key player in China's healthcare sector.

Fact Checked

Verified by Editorial Team

Live Data

Updated 3/6/2026

Wealth Over Time

Portfolio Holdings

STAR CM Holdings Ltd

In-Depth Profile

Early Life and Education

Born in 1965 in Nanchang, Jiangxi Province, Jin Lei's academic journey began at Peking University at age 16. He later earned a master's degree from the Institute of Biophysics under the Chinese Academy of Sciences before pursuing a Ph.D. in medicinal chemistry at the University of California. This education provided a solid foundation for his biomedical innovations.

Rise to Success

Jin Lei's career took a significant turn when he co-founded Jinsai Pharmaceutical in 1997. Under his leadership, the company pioneered the development of recombinant human growth hormones, creating 'firsts' in China's biopharmaceutical history. This success led to Changchun High-tech reaching a peak market valuation of RMB210 billion, solidifying Jin Lei's position in the industry.

Key Business Strategies

Jin Lei's business strategy focused on combining biopharmaceutical technology with domestic market needs. His company launched innovative products that benefited countless patients and established a competitive advantage for Changchun High-tech.

Philanthropy

While the provided sources do not offer specific data on his current philanthropy, it does mention that Lei Jun donated over $2.2 billion worth of Xiaomi shares to charity in 2021. He also donated 1.3 billion yuan to Wuhan University in 2023.

Career Milestones

1997

Co-founded Jinsai Pharmaceutical

Began a new era for China's growth hormone sector and established a strong market position.

1998

Launched China's first recombinant human growth hormone powder injection

Broke foreign monopolies in the market.

2005

Introduced Asia's first recombinant human growth hormone water injection

Enhanced patient medication convenience.

2014

Released globally's first long-acting recombinant human growth hormone water injection

Established China's leadership in global development efforts.

2024

Divorce from Wang Simian

Caused a sharp drop in the stock price of Changchun High-Tech.

Philanthropy & Social Impact

General

Xiaomi Shares to Charity

$2.2B

Donated over $2.2 billion worth of Xiaomi shares to charity

Education

Wuhan University Donation

$0.18B

Donated 1.3 billion yuan to Wuhan University

Controversies & Challenges

2024

Divorce from Wang Simian

Resulted in a sharp decline in Changchun High-Tech's market value, raising concerns about corporate governance.

Compare Jin Lei

Jin Lei vs Jeff Bezos

Compare Wealth →

Net Worth Face-off

Jin Lei vs Mark Zuckerberg

Compare Wealth →